Amanda Brown, CBHPSS, MSW Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 216 14th Ave Sw, Sidney, MT 59270 Phone: 406-488-2100 |
News Archive
The first vaccine to protect against COVID-19 could be approved in the U.S. within days, but legislation to help fund its distribution remains mired in Congress.
Reckitt Benckiser Group PLC today announces it has signed a definitive merger agreement with Schiff Nutrition International, Inc. a leading provider of branded vitamins, nutrition supplements and nutrition bars in the United States and elsewhere. The Board of Directors of Schiff has approved the transaction and will recommend that its stockholders tender their shares into Reckitt Benckiser's previously announced cash tender offer of $42.00 per share, valuing Schiff at $1.4 billion.
Advances in scientific knowledge and drug development technology have provided an opportunity for new approaches to drug development, including the development of drugs for the treatment of rare diseases.
Using a rapid, sensitive, and inexpensive diagnostic tool called MassTag PCR, scientists at Columbia University Mailman School of Public Health's Center for Infection and Immunity implicated a new human rhinovirus as the cause of severe pediatric respiratory tract infections in Europe.
The World Health Organization set a target for the influenza vaccination rate for 2006 of more than 50% of the elderly population and an increase to more than 75% by 2010. These rates have thus far not been achieved in the old German states. In the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2010; 107[48]: 845-50) the working group around Annicka M. Reuss presents rates from flu seasons past.
› Verified 3 days ago